BALTIMORE, MD—According to the Cystic Fibrosis Foundation (CFF), advancements in cystic fibrosis (CF) research and care have doubled life expectancy in the last 30 years for this patient population. In an effort to raise awareness of the disease and share their story of hope and progress, the CFF has declared May to be national CF Awareness Month. Med-IQ is currently engaged in three educational initiatives designed to improve CF patient care and in recognition of CF Awareness Month, Med-IQ invites pulmonologists and other clinicians who manage patients with CF to participate in the recent launch of their online publication, Use It, Lose It, or Something in Between? Expert Perspectives on the Utility of Antibiotic Susceptibility Testing in Cystic Fibrosis Treatment Planning.

This CME-certified activity explores the role of antibiotic susceptibility testing in treatment planning for patients with an acute exacerbation who need intravenous (IV) antibiotic therapy. Pulmonologists and other house staff may be inclined to tailor therapy based on the results of these tests; however, clinical evidence repeatedly demonstrates that regimens based on susceptibility results do not influence clinical outcomes in CF. The online publication addresses this disconnect and discusses other factors that should be considered when selecting an IV antibiotic regimen to treat exacerbations. “Pulmonary exacerbations present inevitable challenges for physicians who care for patients with CF,” said Patrick A. Flume, MD, Professor of Medicine and Pediatrics at

“Pulmonary exacerbations present inevitable challenges for physicians who care for patients with CF,” said Patrick A. Flume, MD, Professor of Medicine and Pediatrics at Medical University of South Carolina in Charleston, SC. “Because treatment approaches for exacerbations are often guided more by art and experience than clinical evidence, my colleagues and I discussed practical strategies for selecting therapies that limit short- and long-term detrimental effects of acute exacerbations. The publication incorporates key points and audio clips from our discussion.”

Faculty

Patrick A. Flume, MD
Professor of Medicine and Pediatrics
Powers-Huggins Endowed Chair for Cystic Fibrosis
Medical University of South Carolina
Charleston, SC

Donald R. (Dutch) VanDevanter, PhD
Adjunct Associate Professor of Pediatrics
Case Western Reserve University School of Medicine
Cleveland, OH

Valerie J. Waters, MD, MSc
Associate Professor, Department of Paediatrics
University of Toronto
Toronto, ON

Natalie E. West, MD, MHS
Assistant Professor of Medicine
Assistant Director, Fellowship Training Program
Division of Pulmonary and Critical Care Medicine
Johns Hopkins University
Baltimore, MD

Clinicians who manage patients with CF are invited to visit www.Med-IQ.com/a846 to read this complimentary publication. For more information, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com.

This activity is approved for AMA PRA Category 1 Credit™.

This activity is supported by an educational grant from Gilead Sciences, Inc.

 

About Med-IQ

Med-IQ, America’s most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.

As a leader in the CME industry, Med-IQ has delivered 32 performance improvement (PI) and quality improvement (QI) initiatives that make use of systems-based training such as Crew Resource Management (CRM) to improve team performance and patient outcomes. These initiatives have achieved improvement in healthcare professional performance, quality of care, and patient outcomes. Med-IQ’s work in this space has been published 30 times in peer-reviewed journals, and the company has been recognized by the Alliance for Continuing Education in the Health Professions for excellence in CEhp research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership and contributions to the CEhp profession (Leadership Award 2015, 2013; Distinguished Fellow Award 2015; President’s Award 2015, 2012; Rising Star Award 2015). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.

To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.

For more information, contact:

Amy Caswell
Senior Audience Development Manager
866 858 7434
info@med-iq.com

Med-IQ
Inspiring Medical Education.